Arvinas LLC(ARVN) - 2025 Q4 - Earnings Call Transcript

Arvinas (NasdaqGS:ARVN) Q4 2025 Earnings call February 24, 2026 08:00 AM ET Company ParticipantsAndrew Saik - CFOAngela Cacace - CSOJeff Boyle - Head of Investor RelationsJonathan Miller - Managing Director of Biotech and Pharma Equity ResearchManoj Radder - VPNoah Berkowitz - CMORandy Teel - President and CEOSrikripa Devarakonda - VP of Biotechnology Equity ResearchConference Call ParticipantsDaniel Bronder - Research AnalystDerek Archila - Managing Director and Co-Head of Therapeutics Research & Senior Bi ...